Quotes 5-day view Delayed London Stock Exchange
10/20/2020
10/21/2020
10/22/2020
10/23/2020
10/26/2020
Date
1486(c)
1439.5(c)
1456(c)
1456.5(c)
1446 Last
921 144
1 550 811
1 304 892
794 287
362 384 Volume
-0.30% -3.13% +1.15% +0.03% -0.72% Change
Sales 2020
4 687 M - -
Net income 2020
401 M - -
Net Debt 2020
1 646 M - -
P/E ratio 2020
42,9x
Yield 2020
1,53%
Sales 2021
5 330 M - -
Net income 2021
710 M - -
Net Debt 2021
1 317 M - -
P/E ratio 2021
23,1x
Yield 2021
2,06%
Capitalization
16 600 M 16 608 M -
EV / Sales 2020
3,89x
EV / Sales 2021
3,36x
Nbr of Employees
17 500
Free-Float
98,7%
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows:
- specialized surgery (73.1%): orthopedics (primarily orthopedic implants ; hips, knees and shoulders) and endoscopy (surgery and damaged tissue repair products, visualization products, etc.);
- wound care (26.9%): skin grafts for major burns victims,...
Notations Surperformance© of Smith & Nephew Plc
Trading Rating : Investor Rating :
All news about SMITH & NEPHEW PLC
News in other languages on SMITH & NEPHEW PLC
Analyst Recommendations on SMITH & NEPHEW PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SMITH & NEPHEW PLC
Short Term Mid-Term Long Term Trends Bearish Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
15
Average target price
23,15 $
Last Close Price
18,99 $
Spread / Highest target
48,5%
Spread / Average Target
21,9%
Spread / Lowest Target
0,54%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
